2
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
15
Prostatic Neoplasms
11
Osteoporosis
6
Neoplasms
4
Melanoma
3
Multiple Myeloma
2
Lymphoma, Non-Hodgkin
2
Cardiovascular Diseases
2
Carcinoma, Non-Small-Cell Lung
2
Wilms Tumor
1
Unspecified Childhood Solid Tumor, Protocol Specific
1
Triple Negative Breast Neoplasms
1
Testicular Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Smoldering Multiple Myeloma
1
Sarcoma, Ewing
1
Regional Osteoporosis as a Result of Chemotherapy
1
Recurrence
1
Primary Ovarian Insufficiency
1
Polycystic Ovary Syndrome
1
Paraganglioma, Extra-Adrenal
1
Pain
1
Ovarian Neoplasms
1
Osteosarcoma
1
Oropharyngeal Neoplasms
1
Neuroblastoma
1
Neoplasms, Plasma Cell
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Monoclonal Gammopathy of Undetermined Significance
1
Interventions
Etoposide
30
Carboplatin
30
Cisplatin
23
Ifosfamide
22
Filgrastim
22
Paclitaxel
18
Peripheral Blood Stem Cell Transplantation
16
Bleomycin
13
Cyclophosphamide
11
Radiotherapy
8
Thiotepa
7
Magnetic Resonance Spectroscopy
6
Gemcitabine
6
pegfilgrastim
5
Therapeutics
5
Polymerase Chain Reaction
5
Melphalan
5
Granulocyte Colony-Stimulating Factor
5
Flow Cytometry
5
Busulfan
5
etoposide phosphate
4
Temozolomide
4
Psychiatric Rehabilitation
4
Oxaliplatin
4
Dexamethasone
4
sargramostim
3
Vinblastine
3
Taxes
3
Surveys and Questionnaires
3
Methylprednisolone
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Testicular Neoplasms
×
Absorptiometry, Photon
×
Clear all
NCT01641172
2024-04-19
TASTY
University Medical Center Groningen
Phase 4
Completed
140 enrolled